The angiome: a new concept in cancer biology
Authors:
- 20 April 2011
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 64 (7) , 637-643
Abstract
Angiogenesis is a key process in cancer biology, and justifies focus on the endothelium. Separate studies have looked at different aspects of angiogenesis and vascular biology, primarily focusing on certain laboratory and imaging techniques that generally reflect one particular aspect of the assessment of the endothelium. These techniques include the secretion/release of molecules (such as growth factors) into the plasma, by the presence of mature and progenitor endothelial cells themselves in the circulation, but also by examination of peripheral blood flow and the local circulation of the tumour, and cells of the tumour itself. However, a limitation of this approach is that these methods, although themselves being useful, have often been viewed in isolation and thus can provide only a part of the vascular picture. The authors submit that this approach is weak, and introduce ‘the angiome’ as a term which fuses several different aspects of endothelial and tumour biology into a single concept. The authors suggest that the adoption of the concept of the angiome will bring improved insights into angiogenesis and thus cancer cell biology. In justifying this concept, the authors review the current understanding of endothelial biology and the methods of its assessment, and hypothesise that a more multifactorial approach to the angiome will be a crucial determinant of outcomes of and treatment strategies for diseases, in particular antiangiogenics for cancer therapy.Keywords
This publication has 121 references indexed in Scilit:
- Association of Inflammatory Markers with Colorectal Cancer Incidence in the Atherosclerosis Risk in Communities StudyCancer Epidemiology, Biomarkers & Prevention, 2011
- Endothelial von Willebrand factor regulates angiogenesisBlood, 2011
- Semiquantitative assessment of the microdistribution of fluorescence‐labeled monoclonal antibody in small peritoneal disseminations of ovarian cancerCancer Science, 2010
- Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2Clinical Cancer Research, 2010
- A critical analysis of current in vitro and in vivo angiogenesis assaysInternational Journal of Experimental Pathology, 2009
- Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculatureAngiogenesis, 2009
- Autocrine VEGF Signaling Is Required for Vascular HomeostasisCell, 2007
- The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancerJournal of Clinical Pathology, 2006
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971